Who owns NOVABAY PHARMACEUTICALS INC?
- Ticker: NBY
- CUSIP Number: 66987p300
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
UBS Group | 221k | $23k | 2496% | Mar 2024 |
|
Two Sigma Securities | 149k | $16k | 836% | Mar 2024 |
|
Geode Capital Management | 25k | $2.6k | 0% | Mar 2024 |
|
Tower Research Capital | 15k | $1.6k | 36% | Mar 2024 |
|
Vanguard Group | 14k | $1.4k | 0% | Mar 2024 |
|
Zacks Investment Management | 10k | $1.0k | 100% | Mar 2024 |
|
Morgan Stanley | 158.00 | $17.000800 | 0% | Mar 2024 |
|
Bank of America Corporation | 86.00 | $9.004200 | 0% | Mar 2024 |
|
Wells Fargo & Company | 51.00 | $4.998000 | 2% | Mar 2024 |
|
Advisor Group Holdings | 37.00 | $3.999700 | 0% | Mar 2024 |
|
Ronald Blue Trust | 37.00 | $3.999700 | 0% | Mar 2024 |
|
Royal Bank of Canada | 15.00 | $0 | 0% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 12.00 | $0.999600 | 100% | Mar 2024 |
|
Addison Advisors | 4.00 | $1.000000 | 0% | Mar 2024 |
|
Who sold out of Novabay Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Dec 2023 | 65k | $13k |
Hudson Bay Capital Management | Dec 2023 | 54k | $11k |
Citadel Advisors | Dec 2023 | 37k | $7.5k |
Hrt Financial | Dec 2023 | 17k | $3.0k |
BlackRock | Sep 2023 | 20.00 | $9.000000 |